Total Payments
$1.2M
2024 Payments
$120,511
Companies
42
Transactions
275
Medicare Patients
980
Medicare Billing
$185,394
Payment Breakdown by Category
Consulting$926,636 (79.9%)
Other$143,380 (12.4%)
Research$67,382 (5.8%)
Travel$15,401 (1.3%)
Food & Beverage$7,178 (0.6%)
Education$23.90 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $926,636 | 32 | 79.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $117,428 | 19 | 10.1% |
| Unspecified | $67,382 | 7 | 5.8% |
| Travel and Lodging | $15,401 | 35 | 1.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $13,800 | 1 | 1.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $12,000 | 2 | 1.0% |
| Food and Beverage | $7,178 | 176 | 0.6% |
| Entertainment | $151.86 | 1 | 0.0% |
| Education | $23.90 | 2 | 0.0% |
Payments by Type
General
$1.1M
268 transactions
Research
$67,382
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Itamar Medical Inc | $632,027 | 13 | $0 (2024) |
| Respicardia, Inc. | $207,230 | 38 | $0 (2020) |
| LivaNova USA, Inc. | $201,217 | 35 | $0 (2024) |
| ZOLL Respicardia, Inc. | $72,328 | 12 | $0 (2024) |
| Philips Electronics North America Corporation | $38,063 | 7 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $4,474 | 14 | $0 (2024) |
| Resmed Corp | $1,352 | 2 | $0 (2022) |
| GlaxoSmithKline, LLC. | $581.86 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $429.52 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $286.46 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120,511 | 54 | Itamar Medical Inc ($65,093) |
| 2023 | $144,716 | 52 | Itamar Medical Inc ($89,379) |
| 2022 | $153,466 | 34 | LivaNova USA, Inc. ($79,627) |
| 2021 | $198,689 | 28 | Itamar Medical Inc ($106,415) |
| 2020 | $260,766 | 27 | Itamar Medical Inc ($150,993) |
| 2019 | $235,330 | 67 | Itamar Medical Inc ($135,141) |
| 2018 | $10,337 | 8 | Respicardia, Inc. ($8,949) |
| 2017 | $36,187 | 5 | Itamar Medical Inc ($21,482) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $46.10 | General |
| Category: Narcoplepsy | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $46.36 | General |
| Category: Narcoplepsy | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $10.07 | General |
| Category: Narcoplepsy | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Pulmonology | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Respiratory | ||||||
| 10/06/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $966.67 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $35.44 | General |
| Category: NEUROLOGY | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 08/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Immunology | ||||||
| 07/23/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: Narcoplepsy | ||||||
| 07/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $33.02 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | LivaNova USA, Inc. | THN Sleep Therapy (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,130.88 | General |
| Category: Neurology | ||||||
| 07/16/2024 | LivaNova USA, Inc. | THN Sleep Therapy (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,039.29 | General |
| Category: Neurology | ||||||
| 07/11/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $40.70 | General |
| Category: Narcoplepsy | ||||||
| 07/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OSPREY LNS005 | LivaNova USA, Inc. | $33,939 | 2 |
| SRC-SLE-Sparkle-PSG-2020-10908 | Philips Electronics North America Corporation | $27,082 | 3 |
| SRC-NBS-Sparkle-EP-2019-10456 | Philips Electronics North America Corporation | $6,360 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 328 | 375 | $245,284 | $64,145 |
| 2022 | 5 | 225 | 260 | $146,807 | $43,140 |
| 2021 | 10 | 268 | 299 | $129,921 | $48,557 |
| 2020 | 6 | 159 | 189 | $71,290 | $29,552 |
Total Patients
980
Total Services
1,123
Medicare Billing
$185,394
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 73 | 114 | $63,840 | $16,423 | 25.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 26 | 26 | $50,622 | $13,395 | 26.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 19 | 20 | $40,760 | $9,731 | 23.9% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 66 | 67 | $31,892 | $8,347 | 26.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 42 | 42 | $28,770 | $7,250 | 25.2% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 72 | 72 | $15,840 | $5,550 | 35.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 17 | 20 | $7,960 | $2,127 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 14 | $5,600 | $1,322 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 79 | 113 | $55,237 | $15,951 | 28.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 21 | 21 | $37,975 | $11,203 | 29.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 40 | 40 | $23,280 | $7,055 | 30.3% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 37 | 37 | $16,935 | $5,067 | 29.9% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 48 | 49 | $13,380 | $3,863 | 28.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 54 | 80 | $31,058 | $11,913 | 38.4% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2021 | 16 | 16 | $22,864 | $9,146 | 40.0% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 16 | 16 | $21,776 | $8,279 | 38.0% |
| 95800 | Study of sleep patterns, including sleep time | Office | 2021 | 45 | 45 | $17,640 | $6,496 | 36.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 28 | 28 | $13,411 | $5,050 | 37.7% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2021 | 40 | 40 | $12,800 | $3,855 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 21 | $5,857 | $2,208 | 37.7% |
| 94762 | Overnight measurement of oxygen saturation in blood using ear or finger device | Office | 2021 | 26 | 27 | $1,485 | $639.82 | 43.1% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 11 | 11 | $1,320 | $579.59 | 43.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 13 | 15 | $1,710 | $391.65 | 22.9% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2020 | 16 | 16 | $21,776 | $8,128 | 37.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2020 | 45 | 45 | $14,400 | $7,961 | 55.3% |
About Dr. Alan Schwartz, M.D
Dr. Alan Schwartz, M.D is a Pulmonary Disease healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639194392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Schwartz, M.D has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $120,511 received in 2024. These payments were reported across 275 transactions from 42 companies. The most common payment nature is "Consulting Fee" ($926,636).
As a Medicare-enrolled provider, Schwartz has provided services to 980 Medicare beneficiaries, totaling 1,123 services with total Medicare billing of $185,394. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Baltimore, MD
- Active Since 07/13/2006
- Last Updated 02/18/2013
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1639194392
Products in Payments
- WatchPat (Device) $307,966
- remede System (Device) $279,558
- THN Sleep Therapy (Device) $201,217
- WatchPAT (Device) $169,589
- WatchPATONE (Device) $154,472
- (2383) SleepUndivided (Device) $33,443
- (8334) IGT_D Peripheral (Device) $4,620
- AIR 11 (Device) $1,200
- TRELEGY ELLIPTA (Drug) $407.42
- DUPIXENT (Biological) $255.83
- GLASSIA (Biological) $251.05
- XYWAV (Drug) $235.44
- WAKIX (Drug) $188.13
- SUNOSI (Drug) $158.11
- ApneaLink (Device) $151.86
- NUCALA (Biological) $137.98
- AIRSUPRA (Drug) $118.97
- OPSUMIT (Drug) $105.86
- OFEV (Drug) $104.33
- Prolastin-C Liquid (Biological) $103.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Baltimore
Robert Wise, M.d, M.D
Pulmonary Disease — Payments: $653,703
Pulmonary Disease $653,703
Hitesh Batra, Md, MD
Pulmonary Disease — Payments: $504,969
Pulmonary Disease $504,969
Hans Lee, Md, MD
Pulmonary Disease — Payments: $421,517
Pulmonary Disease $421,517
Ko-Pen Wang
Pulmonary Disease — Payments: $416,486
Pulmonary Disease $416,486
Christian Merlo, M.d, M.D
Pulmonary Disease — Payments: $183,983
Pulmonary Disease $183,983
Sonye Danoff, M.d, M.D
Pulmonary Disease — Payments: $145,641
Pulmonary Disease $145,641